- To immediately recommend approval.
- To caution that a non-significant result might be due to low power (Type II error) rather than true ineffectiveness, necessitating further investigation.
- To ignore the power and focus on the p-value.
- To recommend disapproval regardless of findings.
75. A critical situational decision needs to be made about whether to release a new drug to market based on clinical trial results. If the trial had low statistical power, what is the urgency for a biostatistician’s caution?
Facebook
WhatsApp
